Journal article icon

Journal article

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids

Abstract:

Background

Growing evidence suggests that blood eosinophil count is associated with patient responsiveness to inhaled corticosteroids (ICS). We performed post hoc predictive modeling on data from the FORWARD study and two replicate studies by Dransfield, to evaluate the relationships between baseline eosinophil count and the effect of ICS on exacerbations and lung function in patients with COPD.

Methods

The studies assessed ICS/long-acting β2 agonist (LABA) combin...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.2147/COPD.S179425

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Oxford college:
St Edmund Hall
Role:
Author
ORCID:
0000-0002-4288-5973
Expand authors...
National Institute for Health Research More from this funder
Chiesi Farmaceutici SpA More from this funder
GlaxoSmithKline More from this funder
Publisher:
Dove Press Publisher's website
Journal:
International Journal of Chronic Obstructive Pulmonary Disease Journal website
Volume:
13
Pages:
3669-3676
Publication date:
2018-11-06
Acceptance date:
2018-10-12
DOI:
ISSN:
1178-2005 and 1176-9106
Pmid:
30464449
Source identifiers:
949005
Language:
English
Keywords:
Pubs id:
pubs:949005
UUID:
uuid:02e4a6b8-3142-4626-af8e-03201f47a67e
Local pid:
pubs:949005
Deposit date:
2018-12-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP